Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cerecor
Biotech
Avalo spirals amid default, spurring attempt to sell assets
After working through a default with its creditors in July, troubled Avalo Therapeutics is looking to sell or license its core assets.
Annalee Armstrong
Aug 3, 2023 10:45am
Apollo lands inflammatory antibody from Avalo for $90M biobucks
Aug 1, 2022 10:36am
Avalo adjusts almost entire pipeline weeks after CEO, CFO depart
Mar 2, 2022 2:43pm
Little Cerecor sees shares jump on COVID-19 readout, seeks EUA
Mar 2, 2021 9:20am
Aurinia poaches CEO Peter Greenleaf from Cerecor
Apr 12, 2019 10:49am
Duke startup Evecxia brings on ex-Cerecor chief as CEO
Aug 16, 2018 10:20am